- Home
- KYMR vs KWR Comparison
KYMR vs KWR Comparison
Compare KYMR & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- KWR
- Stock Information
- Founded
- KYMR 2015
- KWR 1918
- Country
- KYMR United States
- KWR United States
- Employees
- KYMR N/A
- KWR N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- KWR Major Chemicals
- Sector
- KYMR Health Care
- KWR Industrials
- Exchange
- KYMR Nasdaq
- KWR Nasdaq
- Market Cap
- KYMR 3.1B
- KWR 2.5B
- IPO Year
- KYMR 2020
- KWR 1985
- Fundamental
- Price
- KYMR $47.28
- KWR $140.17
- Analyst Decision
- KYMR Strong Buy
- KWR Strong Buy
- Analyst Count
- KYMR 15
- KWR 5
- Target Price
- KYMR $58.53
- KWR $148.60
- AVG Volume (30 Days)
- KYMR 599.5K
- KWR 130.6K
- Earning Date
- KYMR 10-30-2025
- KWR 10-30-2025
- Dividend Yield
- KYMR N/A
- KWR 1.45%
- EPS Growth
- KYMR N/A
- KWR N/A
- EPS
- KYMR N/A
- KWR N/A
- Revenue
- KYMR $44,711,000.00
- KWR $1,832,674,000.00
- Revenue This Year
- KYMR $58.45
- KWR $2.14
- Revenue Next Year
- KYMR N/A
- KWR $5.27
- P/E Ratio
- KYMR N/A
- KWR N/A
- Revenue Growth
- KYMR N/A
- KWR N/A
- 52 Week Low
- KYMR $19.45
- KWR $95.91
- 52 Week High
- KYMR $53.27
- KWR $180.97
- Technical
- Relative Strength Index (RSI)
- KYMR 64.57
- KWR 54.02
- Support Level
- KYMR $42.71
- KWR $136.95
- Resistance Level
- KYMR $44.43
- KWR $142.99
- Average True Range (ATR)
- KYMR 1.98
- KWR 4.39
- MACD
- KYMR 0.60
- KWR -0.92
- Stochastic Oscillator
- KYMR 91.51
- KWR 47.97
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About KWR Quaker Houghton
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.